These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 32194847)

  • 1. FDG uptake in cancer: a continuing debate.
    Peppicelli S; Andreucci E; Ruzzolini J; Bianchini F; Calorini L
    Theranostics; 2020; 10(7):2944-2948. PubMed ID: 32194847
    [No Abstract]   [Full Text] [Related]  

  • 2. New aspects of the Warburg effect in cancer cell biology.
    Bensinger SJ; Christofk HR
    Semin Cell Dev Biol; 2012 Jun; 23(4):352-61. PubMed ID: 22406683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positron-emitting radiopharmaceuticals: how safe are they?
    Silberstein EB
    Cancer Biother Radiopharm; 2001 Feb; 16(1):13-5. PubMed ID: 11279793
    [No Abstract]   [Full Text] [Related]  

  • 4. Association between pulmonary uptake of fluorodeoxyglucose detected by positron emission tomography scanning after radiation therapy for non-small-cell lung cancer and radiation pneumonitis.
    Mac Manus MP; Ding Z; Hogg A; Herschtal A; Binns D; Ball DL; Hicks RJ
    Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1365-71. PubMed ID: 20675076
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Mitchell KG; Amini B; Wang Y; Carter BW; Godoy MCB; Parra ER; Behrens C; Villalobos P; Reuben A; Lee JJ; Weissferdt A; Moran CA; Fujimoto J; Sepesi B; Walsh GL; Vaporciyan AA; Hofstetter WL; William WN; Gibbons DL; Wang J; Hwu P; Swisher SG; Piwnica-Worms D; Kadara H; Wistuba II; Heymach JV; Peng W; Cascone T
    Cancer Immunol Immunother; 2020 Aug; 69(8):1519-1534. PubMed ID: 32300858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The reverse Warburg effect and 18F-FDG uptake in non-small cell lung cancer A549 in mice: a pilot study.
    Zhang G; Li J; Wang X; Ma Y; Yin X; Wang F; Zheng H; Duan X; Postel GC; Li XF
    J Nucl Med; 2015 Apr; 56(4):607-12. PubMed ID: 25722447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aerobic glycolysis in cancers: implications for the usability of oxygen-responsive genes and fluorodeoxyglucose-PET as markers of tissue hypoxia.
    Busk M; Horsman MR; Kristjansen PE; van der Kogel AJ; Bussink J; Overgaard J
    Int J Cancer; 2008 Jun; 122(12):2726-34. PubMed ID: 18351643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the biological effects of (18)F at different intracellular levels.
    Kashino G; Hayashi K; Douhara K; Kobashigawa S; Mori H
    Biochem Biophys Res Commun; 2014 Nov; 454(1):7-11. PubMed ID: 25301551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling the relationship between fluorodeoxyglucose uptake and tumor radioresistance as a function of the tumor microenvironment.
    Jeong J; Deasy JO
    Comput Math Methods Med; 2014; 2014():847162. PubMed ID: 25276223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PET-associated incidental neoplasms of the thyroid.
    Katz SC; Shaha A
    J Am Coll Surg; 2008 Aug; 207(2):259-64. PubMed ID: 18656056
    [No Abstract]   [Full Text] [Related]  

  • 11. The Warburg effect: persistence of stem-cell metabolism in cancers as a failure of differentiation.
    Riester M; Xu Q; Moreira A; Zheng J; Michor F; Downey RJ
    Ann Oncol; 2018 Jan; 29(1):264-270. PubMed ID: 29045536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revisit 18F-fluorodeoxyglucose oncology positron emission tomography: "systems molecular imaging" of glucose metabolism.
    Shen B; Huang T; Sun Y; Jin Z; Li XF
    Oncotarget; 2017 Jun; 8(26):43536-43542. PubMed ID: 28402949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of FDG-PET findings on decisions regarding patient management strategies: a multicenter trial in patients with lung cancer and other types of cancer.
    Kubota K; Matsuno S; Morioka N; Adachi S; Koizumi M; Seto H; Kojo M; Nishioka S; Nishimura M; Yamamoto H
    Ann Nucl Med; 2015 Jun; 29(5):431-41. PubMed ID: 25812534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-specific positron emission tomography imaging in patients: [18F] fluorodeoxyglucose and beyond.
    Mankoff DA; Eary JF; Link JM; Muzi M; Rajendran JG; Spence AM; Krohn KA
    Clin Cancer Res; 2007 Jun; 13(12):3460-9. PubMed ID: 17575208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OCCUPATIONAL RADIATION DOSE TO NUCLEAR MEDICINE STAFF DUE TO TC99M, F18-FDG PET AND THERAPEUTIC I-131 BASED EXAMINATIONS.
    Fathy M; Khalil MM; Elshemey WM; Mohamed HS
    Radiat Prot Dosimetry; 2019 Dec; 186(4):443-451. PubMed ID: 30989207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia and glucose metabolism in malignant tumors: evaluation by [18F]fluoromisonidazole and [18F]fluorodeoxyglucose positron emission tomography imaging.
    Rajendran JG; Mankoff DA; O'Sullivan F; Peterson LM; Schwartz DL; Conrad EU; Spence AM; Muzi M; Farwell DG; Krohn KA
    Clin Cancer Res; 2004 Apr; 10(7):2245-52. PubMed ID: 15073099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Positron emission tomography (PET) and (F-18)-fluorodeoxyglucose in (FDG) in cancerology].
    Maublant J; Vuillez JP; Talbot JN; Lumbroso J; Muratet JP; Herry JY; Artus JC
    Bull Cancer; 1998 Nov; 85(11):935-50. PubMed ID: 9951421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cardiac arrest during TEP-scan].
    Baize A; Sculier JP; Dusarf M; Berghmans T
    Rev Med Brux; 2009; 30(2):111-3. PubMed ID: 19517908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer screening by FDG-PET: benefit or risk?
    Hatazawa J
    Ann Nucl Med; 2011 Nov; 25(9):667-8. PubMed ID: 21987285
    [No Abstract]   [Full Text] [Related]  

  • 20. Combined hyperpolarized
    Hansen AE; Gutte H; Holst P; Johannesen HH; Rahbek S; Clemmensen AE; Larsen MME; Schøier C; Ardenkjaer-Larsen J; Klausen TL; Kristensen AT; Kjaer A
    Eur J Radiol; 2018 Jun; 103():6-12. PubMed ID: 29803387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.